Ose Immunotherapeutics
Clinical trials sponsored by Ose Immunotherapeutics, explained in plain language.
-
New cancer drug trial seeks to boost immune system against tumors
Disease control Recruiting nowThis early-stage clinical trial is testing a new immunotherapy drug called OSE-279 in people with advanced solid tumors or lymphomas. The study has three parts: first finding the safest dose, then testing safety when combined with another drug for lung cancer, and finally measuri…
Phase: PHASE1, PHASE2 • Sponsor: OSE Immunotherapeutics • Aim: Disease control
Last updated Apr 03, 2026 14:43 UTC
-
New hope for lung cancer patients when first immunotherapy fails
Disease control Recruiting nowThis study is testing whether a new immunotherapy called OSE2101 works better than standard chemotherapy for people with advanced non-small cell lung cancer. It is for patients whose cancer initially responded to immunotherapy but then started growing again. About 363 participant…
Phase: PHASE3 • Sponsor: OSE Immunotherapeutics • Aim: Disease control
Last updated Mar 02, 2026 15:28 UTC